Medevice Capital
Medevice is a venture capital firm based in Paris, France, founded in 2011. The firm specializes in investing in medical technology and e-health innovation projects, focusing on healthcare, digital health, and wellness sectors within the region. With a team composed of experienced entrepreneurs who have worked in healthcare companies, Medevice possesses a deep understanding of the potential of various projects. This expertise enables the firm to provide meaningful support to emerging companies as they navigate challenges in the industry.
Dyameo is a medical technology company focused on developing single-use endoscopic probes that enable the immediate detection of cancer cells. These innovative probes are designed for in-vivo diagnostics and assist medical professionals in identifying cancer cells at an early stage during endoscopic examinations. By providing a reliable tool for cancer detection, Dyameo aims to enhance the accuracy and efficiency of cancer diagnoses, ultimately contributing to improved patient outcomes.
IMACTIS SAS, established in 2009 and based in La Tronche, France, specializes in developing innovative solutions for interventional radiology. The company focuses on assisting radiologists during minimally invasive procedures such as biopsies, tumor ablations, vertebroplasties, infiltrations, and drainages. IMACTIS's technology enhances accuracy and safety, facilitates complex interventions, and reduces procedure duration while minimizing the need for additional controls. By providing tools that allow for easier multi-needle alignment and real-time treatment planning, the company aims to improve patient outcomes and overall care in medical institutions. In addition to its product offerings, IMACTIS also engages in clinical studies to further advance the field of interventional radiology.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.